{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:49:15Z","timestamp":1794473355897,"version":"4.9.1"},"reference-count":21,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,1,31]]},"DOI":"10.1536\/ihj.23-375","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T22:17:31Z","timestamp":1706653051000},"page":"146-151","source":"Crossref","is-referenced-by-count":1,"title":["Is Moderate\/Large Residual Shunt After PFO Closure Justifiable for a Patient with a Prior History of Cryptogenic Stroke and Transient Ischemic Attack?"],"prefix":"10.1536","volume":"65","author":[{"given":"Francesco","family":"Melillo","sequence":"first","affiliation":[{"name":"Echo Laboratory, Clinica Montevergine di Mercogliano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Popusoi","sequence":"additional","affiliation":[{"name":"Invasive Cardiology Unit, Clinica Montevergine di Mercogliano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Frecentese","sequence":"additional","affiliation":[{"name":"Echo Laboratory, Clinica Montevergine di Mercogliano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Miano","sequence":"additional","affiliation":[{"name":"Echo Laboratory, Clinica Montevergine di Mercogliano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Santoro","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Clinica Montevergine di Mercogliano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Tesorio","sequence":"additional","affiliation":[{"name":"Invasive Cardiology Unit, Clinica Montevergine di Mercogliano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustaquio Maria","family":"Onorato","sequence":"additional","affiliation":[{"name":"University Cardiology Department, IRCCS Galeazzi-Sant'Ambrogio Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Saver JL, Carroll JD, Thaler DE, <i>et al<\/i>. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 2017; 377: 1022-32.","DOI":"10.1056\/NEJMoa1610057"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mas JL, Derumeaux G, Guillon B, <i>et al<\/i>. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 2017; 377: 1011-21.","DOI":"10.1056\/NEJMoa1705915"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. S\u00f8ndergaard L, Kasner SE, Rhodes JF, <i>et al<\/i>. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 2017; 377: 1033-42.","DOI":"10.1056\/NEJMoa1707404"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shah R, Nayyar M, Jovin IS, <i>et al<\/i>. Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis. Ann Intern Med 2018; 168: 335-42.","DOI":"10.7326\/M17-2679"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Carroll AM, Carroll JD. Device closure of patent foramen ovale for cryptogenic stroke: patient selection and outcomes according to new randomized trials. Curr Cardiol Rep 2019; 21: 48.","DOI":"10.1007\/s11886-019-1137-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Caputi L, Butera G, Parati E, <i>et al<\/i>. Italian patent foramen ovale survey (I.P.O.S.): early results. Perspect Med. Bartels G, Bartels S, Poppert H, eds. <i>New Trends in Neurosonology and Cerebral Hemodynamics - An Update<\/i>. New York: Elsevier; 2012: 236-40.","DOI":"10.1016\/j.permed.2012.02.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Caputi L, Butera G, Anzola GP, <i>et al<\/i>. Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey. J Stroke Cerebrovasc Dis 2013; 22: e219-26.","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.12.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matsumura K, Gevorgyan R, Mangels D, Masoomi R, Mojadidi MK, Tobis J. Comparison of residual shunt rates in five devices used to treat patent foramen ovale. Catheter Cardiovasc Interv 2014; 84: 455-63.","DOI":"10.1002\/ccd.25453"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Schwerzmann M, Windecker S, Wahl A, <i>et al<\/i>. Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv 2004; 63: 490-5.","DOI":"10.1002\/ccd.20221"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Diaz T, Cubeddu RJ, Rengifo-Moreno PA, <i>et al<\/i>. Management of residual shunts after initial percutaneous patent foramen ovale closure: A single center experience with immediate and long-term follow-up. Catheter Cardiovasc Interv 2010; 76: 145-50.","DOI":"10.1002\/ccd.22475"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Majunke N, Wallenborn J, Baranowski A, Wunderlich N, Sievert H. Device closure of residual shunt after percutaneous closure of patent foramen ovale. EuroIntervention 2010; 5: 833-7.","DOI":"10.4244\/EIJV5I7A139"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Susuri N, Obeid S, Ulmi M, <i>et al<\/i>. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale. EuroIntervention 2017; 13: 858-66.","DOI":"10.4244\/EIJ-D-17-00061"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Butera G, Sarabia JF, Saracino A, Chessa M, Piazza L, Carminati M. Residual shunting after percutaneous PFO closure: how to manage and how to close. Catheter Cardiovasc Interv 2013; 82: 950-8.","DOI":"10.1002\/ccd.25097"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Meier B. Iatrogenic atrial septal defect, erosion of the septum primum after device closure of a patent foramen ovale as a new medical entity. Catheter Cardiovasc Interv 2006; 68: 165-8.","DOI":"10.1002\/ccd.20584"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Scacciatella P, Biava LM, Marra S. Iatrogenic erosion of the septum primum resulting in an atrial septal defect with left-to-right shunt: a rare pitfall of patent foramen ovale percutaneous closure. Catheter Cardiovasc Interv 2014; 84: 494-6.","DOI":"10.1002\/ccd.25333"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. He L, Cheng G, Du Y, Zhang Y. Importance of persistent right-to-left shunt after patent foramen ovale closure in cryptogenic stroke patients. Tex Heart Inst J 2020; 47: 244-9.","DOI":"10.14503\/THIJ-17-6582"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gevorgyan Fleming R, Kumar P, West B, <i>et al<\/i>. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale. Catheter Cardiovasc Interv 2020; 95: 365-72.","DOI":"10.1002\/ccd.28527"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wahl A, Tai T, Praz F, <i>et al<\/i>. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the Amplatzer PFO occluder without intraprocedural echocardiography: effect of device size. JACC Cardiovasc Intv 2009; 2: 116-23.","DOI":"10.1016\/j.jcin.2008.09.013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Deng W, Yin S, McMullin D, <i>et al<\/i>. Residual shunt after patent foramen ovale closure and long-term stroke recurrence: A prospective cohort study. Ann Intern Med 2020; 172: 717-25.","DOI":"10.7326\/M19-3583"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Pristipino C, Sievert H, D&apos;Ascenzo F, <i>et al<\/i>. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J 2019; 40: 3182-95.","DOI":"10.1093\/eurheartj\/ehy649"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Rajani R, Lee L, Sohal M, Khawaja MZ, Hildick-Smith D. Redo patent foramen ovale closure for persistent residual right-to-left shunting. EuroIntervention 2011; 6: 735-9.","DOI":"10.4244\/EIJV6I6A124"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-375\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T04:11:00Z","timestamp":1706933460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-375\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.23-375","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"article-number":"23-375"}}